Epstein-Barr Virus Infections - 22 Studies Found
| Completed |
: EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients : Epstein-Barr Virus Infections : 2009-08-20 |
| Active, not recruiting |
: Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents :
|
| Completed |
: Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs) : Epstein-Barr Virus Infections : 2003-04-08 : Biological: Intravenous injection of EBV specific CTLS The |
| Recruiting |
: Mental Training for CFS Following EBV Infection in Adolescents :
: Behavioral: Mental training |
| Completed |
: Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations : Epstein-Barr Virus Infections : 2003-10-07 |
| Completed |
: Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts : Epstein-Barr Virus Infections : 2003-04-11 : Biological: EBV specific T cells One injection of 2x10^7 cells/m2 from Day 45 post transplant. If EBV DN |
| Active, not recruiting |
: A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma :
: 2013-02-25 : Drug: MVA-EBNA1/LMP2 vaccine |
| Completed |
: Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus :
: 2000-06-24 |
| Completed |
: Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs). :
|
| Active, not recruiting |
: Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy :
: 2010-03-26 : Biological: Recombinant Epstein-Barr Virus (EBV) Vaccine |